Brivoligide

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameBrivoligide
Drug Alias NameAYX-1
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionEarly Growth Response Protein 1 inhibitors
TargetsEarly Growth Response Protein 1
Therapy Area/IndicationsPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAdynxx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdynxx Inc
Active IndicationsN/A
Inactive IndicationsPain, Postoperative

Other Information

ATC CodeN/A
Related LinksN/A